Portman Square Capital LLP has filed its 13F form on July 29, 2025 for Q2 2025 where it was disclosed a total value porftolio of $2.48 Billion distributed in 177 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Insulet Corp with a value of $13.1M, Wayfair Inc. with a value of $9.45M, Bridge Bio Pharma, Inc. with a value of $6.29M, Alnylam Pharmaceuticals, Inc. with a value of $2.27M, and Lowes Companies Inc with a value of $2.04M.

Examining the 13F form we can see an decrease of $675M in the current position value, from $3.16B to 2.48B.

Portman Square Capital LLP is based out at London, X0

Below you can find more details about Portman Square Capital LLP portfolio as well as his latest detailed transactions.

Portfolio value $2.48 Billion
Technology: $411 Million
Industrials: $362 Million
Financial Services: $362 Million
Utilities: $345 Million
Consumer Cyclical: $301 Million
Communication Services: $158 Million
Energy: $119 Million
Basic Materials: $116 Million
Other: $307 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 177
  • Current Value $2.48 Billion
  • Prior Value $3.16 Billion
  • Filing
  • Period Q2 2025
  • Filing Date July 29, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 23 stocks
  • Additional Purchases 7 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 12 stocks
Track This Portfolio

Track Portman Square Capital LLP Portfolio

Follow Portman Square Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portman Square Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Portman Square Capital LLP with notifications on news.